1 |
Kassab K, Soni R, Kassier A, Fischell TA. The Potential Role of Renal Denervation in the Management of Heart Failure. J Clin Med 2022;11:4147. [PMID: 35887912 DOI: 10.3390/jcm11144147] [Reference Citation Analysis]
|
2 |
Xue F, Cheng J, Liu Y, Cheng C, Zhang M, Sui W, Chen W, Hao P, Zhang Y, Zhang C. Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduct Target Ther 2022;7:259. [PMID: 35909160 DOI: 10.1038/s41392-022-01054-3] [Reference Citation Analysis]
|
3 |
D’elia JA, Bayliss GP, Weinrauch LA. The Diabetic Cardiorenal Nexus. IJMS 2022;23:7351. [DOI: 10.3390/ijms23137351] [Reference Citation Analysis]
|
4 |
Tadic M, Cuspidi C. Sacubitril/Valsartan in the Treatment of Resistant Hypertension: Raising Star or Illusion? J Clin Med 2022;11:3081. [PMID: 35683468 DOI: 10.3390/jcm11113081] [Reference Citation Analysis]
|
5 |
Sauer AJ. Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number? J Am Coll Cardiol 2022;80:19-21. [PMID: 35772912 DOI: 10.1016/j.jacc.2022.04.037] [Reference Citation Analysis]
|
6 |
Briasoulis A, Kuno T, Asleh R, Doulamis IP, Malik A. Evolution of In-Hospital Outcomes Among Left Ventricular Assist Device Recipients. Am J Cardiol 2022:S0002-9149(22)00722-6. [PMID: 35906126 DOI: 10.1016/j.amjcard.2022.06.053] [Reference Citation Analysis]
|
7 |
Jensen J, Omar M, Kistorp C, Gustafsson F, Køber L, Møller JE, Schou M. Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives. Basic Clin Pharmacol Toxicol 2022;131:5-17. [PMID: 35510595 DOI: 10.1111/bcpt.13739] [Reference Citation Analysis]
|
8 |
Kalogeropoulos AP, Tam E. Intravenous iron in heart failure with reduced ejection fraction: just about right. Eur J Heart Fail 2022. [PMID: 35481845 DOI: 10.1002/ejhf.2520] [Reference Citation Analysis]
|
9 |
DeVore AD, Bosworth HB, Granger BB. Improving implementation of evidence-based therapies for heart failure. Clin Cardiol 2022;45 Suppl 1:S52-9. [PMID: 35789019 DOI: 10.1002/clc.23845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
10 |
Kang C, Lamb YN. Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction. Am J Cardiovasc Drugs 2022. [PMID: 35624347 DOI: 10.1007/s40256-022-00538-5] [Reference Citation Analysis]
|